The annual meeting of the European Association for the Study of Diabetes was held in Barcelona, Spain in September. Research presented at the meeting covered risks of sulfonylureas, pioglitazone and macular edema, treatment intensification and
Recent evidence suggests it may improve the prognosis of patients with cancer (see the“ Keeping tabs” section in this issue).
The benefits of metformin treatment were highlighted by a few intriguing studies published in the past month.
Predicting cardiovascular events in patients with type 2 diabetes was the focus of multiple recent studies.
Several recent studies addressed the effects of diabetes and diabetes treatments on cardiovascular risk.
A couple of significant studies in type 1 diabetes came out last month.
Managing diabetes can negatively impact quality of life for people with the disease, so doctors should consider a patient's treatment burden and the “whole person” when setting goals, 2 studies suggest.
The risks and consequences of hypoglycemia were described by several studies published recently.
Three comparisons of bariatric surgery and medical management for obese type 2 diabetes patients were recently published in journals of the American Medical Association.
Several recent analyses of national health care data assessed the prevalence of diabetes and its complications in the U.S.